Boston.com: Seven Startups Fighting Cancer

Roughly 7.6 million people in the world die due to cancer every year, according to the Center for Disease Control. Biotechnologists in the Greater Boston area are working to change that.

We’ve come up with a list of seven startups that are working on fighting the disease by improving its detection, developing computer models to better understand it with big data, and finding new ways to cure it.

GNS Healthcare » News & Events

Computerworld: Data-Driven Companies Outperform Competitors Financially

Working with and making business decisions based on data is good for your company’s bottom line. Companies that have embraced a data-driven culture–rating themselves substantially ahead of their peers in their use of data–are three times more likely to rate themselves as substantially ahead of their peers in financial performance, according to findings by the Economist Intelligence Unit in a survey sponsored by Tableau Software.

…The top-performing companies don’t just leave data in the hands of specialists. They seek to democratize data use. Fifty percent of the top-performing companies said training employees to be more data literate is highly important.

Colin Hill, CEO at GNS Healthcare notes that in-house experts create the algorithms behind the tools it uses to assess the comparative effectiveness of different drugs, but the tools themselves are designed to be used by employees across the healthcare industry.

“Part of this is about making the complex simple,” Hill says. “Computers are very good at the complex, but ultimately we have to break it down to the human level.”

“Leading companies realize that being successful means giving people the opportunity to work with data,” says Elissa Fink, chief marketing officer at Tableau Software. “Making data available and easy to use for all employees can transform an organization’s culture. It’s good for the company’s bottom line.”

GNS Healthcare » News & Events

Wall Street Journal: Big Data Can Bring Patients to Water But It Can’t Make Them Think

As it prepares to vie for new business from some of the 30 million additional people entering health exchanges through the Affordable Care Act next year Aetna Inc. is looking to analytics as a means of lowering the cost of some coverage. According to Michael Palmer, head of innovation for the Hartford, Conn.-based insurance company, Aetna is using a new analytic platform to predict which ailments its members are likely to contract over the coming year in order to lower the odds that they will develop cardiovascular disease, one of the more expensive and endemic diseases it has to cover.

This information could help improve health outcomes for patients, dramatically lowering health care costs for themselves, their employers and Aetna itself, says Mr. Palmer. “Better outcomes also lead to better costs. It’s a virtuous cycle,” he told CIO Journal Wednesday after a presentation at the Structure: Data conference in New York. But Mr. Palmer also noted that it’s difficult to get people to act on the information they’re given, even if it’s for their own good…

Aetna uses analytic technology from GNS Healthcare for its predictive work on metabolic syndrome, and works with another half-dozen startups for other Big Data projects. He said Aetna works with larger vendors as well, but says the smaller companies innovate more quickly and “drive things at speed.”

GNS Healthcare » News & Events

Wall Street Journal: New Rivals Clip Oracle’s Wings

If there was one constant in Silicon Valley over the last decade, it was the near steady, profitable growth of Oracle Corp. No longer.

Oracle remains a dominant force in technology with $ 32.7 billion in revenue and database and applications software used by corporations to manage their finances and procurement. Today, its business is being eroded at the edges by smaller, more focused companies offering newer technology…

When insurance giant Aetna Inc. went looking for technology to help it analyze disparate data types concerning 18 million customers, it didn’t look to established vendors such as Oracle. Michael Palmer, Aetna’s head of innovation, said incumbent vendors move too slowly, and that startups such as GNS Healthcare are more apt to more quickly and “drive things at speed.”

GNS Healthcare » News & Events

Boston BD Biotech Conference

CEO Colin Hill will speak on the panel “How are Companies Preparing for the Changing Reimbursement Landscape,” along with Steven Bloom of Ziopharm Oncology, John Brooks of Joslin Diabetes Center, Lawson Macartney of Ambrx, and moderator Peter Thompson of OrbiMed Advisors, on Wednesday, April 3 from 2:30pm-3:00pm at the Four Seasons Hotel in Boston.

GNS Healthcare » News & Events